Inmed Pharmaceuticals Inc (INM)

Apr 29, 2025

SEC Form PRE 14A filed by InMed Pharmaceuticals Inc. - Quantisnow

Apr 29, 2025

Apr 26, 2025

InMed Pharmaceuticals cancels special shareholder meeting By Investing.com - Investing.com Canada

Apr 26, 2025

Apr 25, 2025

InMed Pharmaceuticals cancels special shareholder meeting - Investing.com

Apr 25, 2025

Apr 08, 2025

InMed Pharmaceuticals sets date for special shareholder meeting By Investing.com - Investing.com South Africa

Apr 08, 2025

Apr 08, 2025

InMed Pharmaceuticals sets date for special shareholder meeting - Investing.com

Apr 08, 2025

Apr 07, 2025

InMed Pharmaceuticals stock hits 52-week low at $1.72 - Investing.com Australia

Apr 07, 2025

Apr 07, 2025

InMed Pharmaceuticals stock hits 52-week low at $1.72 By Investing.com - Investing.com South Africa

Apr 07, 2025

Apr 07, 2025

InMed Pharmaceuticals : Expands on Announcement of Cannabinol (CBN) Therapeutic Leadership with New Website Content and CEO Interview - MarketScreener

Apr 07, 2025

Mar 29, 2025

InMed Pharmaceuticals Stock Hits 52-Week Low at $2.34 By Investing.com - Investing.com India

Mar 29, 2025

Mar 28, 2025

InMed Pharmaceuticals Stock Hits 52-Week Low at $2.34 - Investing.com India

Mar 28, 2025

Mar 05, 2025

InMed Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Mar 05, 2025

Feb 18, 2025

InMed Pharmaceuticals Struggles with Losses Amid Revenue Decline - MSN

Feb 18, 2025

Feb 15, 2025

InMed Pharmaceuticals Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update - Defense World

Feb 15, 2025

Feb 14, 2025

InMed Pharmaceuticals Board Reshuffle After Director Resignation - TipRanks

Feb 14, 2025

Feb 13, 2025

InMed Pharmaceuticals Reports Q2 2025 Financial Results - TipRanks

Feb 13, 2025

Feb 12, 2025

InMed Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update - Yahoo Finance

Feb 12, 2025

Feb 12, 2025

InMed Pharmaceuticals Inc. (INM) reports earnings - Quartz

Feb 12, 2025

Feb 12, 2025

InMed Pharmaceuticals Inc. SEC 10-Q Report - TradingView

Feb 12, 2025

Feb 06, 2025

InMed Advances INM-089 for Dry AMD Treatment with New Intravitreal Formulation - TipRanks

Feb 06, 2025

Feb 04, 2025

Inmed selects IVT formulation of INM-089 for dry AMD - BioWorld Online

Feb 04, 2025

Feb 03, 2025

InMed advances AMD treatment with promising IVT drug formulation - MSN

Feb 03, 2025

Feb 03, 2025

Revolutionary Eye Drug INM-089 Achieves 10X Therapeutic Levels in Macular Degeneration Treatment - StockTitan

Feb 03, 2025

Jan 24, 2025

Inmed Pharmaceuticals Inc (INM-Q) QuotePress Release - The Globe and Mail

Jan 24, 2025

Jan 24, 2025

InMed Pharmaceuticals (NASDAQ: INM) Secures International Patent for Novel Compounds - Defense World

Jan 24, 2025

Jan 22, 2025

InMed Pharmaceuticals Secures Key Patent for Cannabinoid Analogs - TipRanks

Jan 22, 2025

Jan 22, 2025

InMed Pharmaceuticals secures international patent - Investing.com India

Jan 22, 2025

Jan 22, 2025

InMed Pharmaceuticals Announces Granting of Patent for Novel Compounds - Newsfile

Jan 22, 2025

Jan 22, 2025

InMed Secures Breakthrough 20-Year Patent in Mexico for Novel Cannabinoid Compounds - StockTitan

Jan 22, 2025

Jan 22, 2025

Nano-Cap InMed Ignites Retail Frenzy As Stock Soars After Alzheimer's Drug Trial Shows Promise - Asianet Newsable

Jan 22, 2025

Jan 22, 2025

InMed Pharmaceuticals (NASDAQ: INM) Announces Positive Results from INM-901 Alzheimer’s Disease Study - Defense World

Jan 22, 2025

Jan 21, 2025

InMed Hails Alzheimer's Study, Stocks Shoot Higher - Baystreet.ca

Jan 21, 2025

Jan 21, 2025

InMed announces ‘positive’ results from in vivo preclinical Alzheimer’s study - TipRanks

Jan 21, 2025

Jan 21, 2025

InMed’s INM-901 Shows Promising Results in Preclinical Alzheimer’s Study - TipRanks

Jan 21, 2025

Jan 21, 2025

InMed's INM-901 Demonstrates Statistically Significant Reduction in Neuroinflammation in a Long-Term Preclinical Alzheimer's Disease Study - Newsfile

Jan 21, 2025

Jan 04, 2025

SABBY MANAGEMENT, LLC Acquires Shares in InMed Pharmaceuticals I - GuruFocus

Jan 04, 2025

Dec 21, 2024

InMed Pharmaceuticals Inc. Holds 2024 Annual General Meeting – Elects Directors and Appoints Auditor - Defense World

Dec 21, 2024

Dec 18, 2024

InMed Pharmaceuticals Director Faces Resignation After Shareholder Vote at Annual Meeting - StockTitan

Dec 18, 2024

Dec 18, 2024

InMed Announces Results of 2024 Annual General Meeting - Newsfile

Dec 18, 2024

Dec 18, 2024

InMed Pharmaceuticals Inc. announced that it expects to receive CAD 10 million in funding - Marketscreener.com

Dec 18, 2024

Dec 17, 2024

InMed Enters Into Standby Equity Purchase Agreement - Newsfile

Dec 17, 2024

Dec 17, 2024

Head-To-Head Review: InMed Pharmaceuticals (NASDAQ:INM) & Rocket Pharmaceuticals (NASDAQ:RCKT) - Defense World

Dec 17, 2024